MedX extends closing date for $2.5 million private placement

MISSISSAUGA, Ontario - MedX Health Corp. (TSX-V:MDX) announced Monday it will extend the closing date for its previously announced non-brokered private placement by up to 30 days. The company, currently valued at $82.09 million, is seeking to raise up to $2.5 million through the offering, which has already received conditional acceptance from the TSX Venture Exchange.

The private placement, first announced on July 25, 2025, consists of up to 33,333,333 units priced at $0.075 per unit. Each unit includes one common share and one-half of a share purchase warrant. Each whole warrant will allow the purchase of an additional common share at $0.10 within one year of issuance. The company’s stock has shown significant momentum, posting a 39.47% return over the past six months, according to InvestingPro data.

According to the company’s statement, the placement may close in tranches and requires a minimum subscription of $500,000. Proceeds will fund development of MedX’s SIAscopy on DermSecure telemedicine platform, support the launch of its technology in the occupational health market, and address general corporate purposes. With a current ratio of 0.38, the funding comes at a crucial time as short-term obligations exceed liquid assets. InvestingPro analysis reveals 8 additional key financial insights available to subscribers.

The company noted that certain insiders may participate in the placement. Qualified agents will receive an 8% cash commission on proceeds from subscribers they introduce, plus agent’s warrants equal to 8% of those subscriptions.

MedX Health specializes in non-invasive skin assessment and teledermatology solutions. Its technology is cleared for use in multiple markets including Canada, the United States, Australia, the European Union, and Turkey.

The information in this article is based on a press release statement from MedX Health Corp.

In other recent news, MedX Health Corp. announced its intention to raise up to $2.5 million through a non-brokered private placement. The company plans to issue up to 33,333,334 units at a price of $0.075 per unit. Each unit will include one common share and one-half of a share purchase warrant. These warrants will allow holders to purchase an additional common share at $0.10 within a year of issuance. This move is part of MedX Health’s efforts to strengthen its financial position. The private placement aims to provide the company with additional capital for its operations. Details regarding the use of the funds were not disclosed. Investors might view this as an opportunity to engage with the company’s future prospects.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.